Medical Affairs Japan Part II: Future Outlook
This webinar, a continuation from April 27, analyzes the future of Medical Affairs in Japan while discussing what we can do together to make Medical Affairs in Japan even more effective.
This webinar, a continuation from April 27, analyzes the future of Medical Affairs in Japan while discussing what we can do together to make Medical Affairs in Japan even more effective.
This white paper by the MAPS Executive Consortium synthesizes the views of senior global Medical Affairs leaders to provide a unified vision for the future of Medical Affairs in society, industry, teams and as individuals.
This webinar shows how identifying areas of opportunity with current available data, and pushing teams to put our patients at the center of our efforts, we can begin implementing novel impact methodologies.
In this interview recorded at MAPS 2022 Global with Lobna Salem we discuss building a Medical Affairs department from the ground up.
This paper explores the Medical Affairs-based medical insights function and and identifies basic operational elements required to establish medical insights as a core strategic MA function.
What is Medical Affairs and what does it do in the biopharmaceutical and MedTech industries? Who works in Medical Affairs and what skills do you need to succeed? Find out in this essential guide to understanding, joining and thriving in Medical Affairs.
This webinar analyzes the current state of Medical Affairs in Japan, highlights progress made and provides suggestions on what we can do together to make Medical Affairs in Japan even more effective.
In this interview recorded at MAPS 2022 Global with Monica de Abadal, SVP, Head North America Medical Affairs, Ipsen, we discuss how Medical Affairs benefits patients and society.
This podcast, recorded at the MAPS 2022 Global Annual Meeting, addresses the unique position of Medical Affairs in the rare disease space & how our work in this area is essential for patient benefit.
Charlotte Kremer (former Astellas) speaks with Danie du Plessis (Kyowa Kirin) and Bjorn Oddens (Merck) about whether Medical Affairs is truly the third strategic pillar.
